Kissei Pharmaceutical Co., Ltd.
Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.
-
New pill may offer relief from fibroid pain and heavy periods
Symptom relief CompletedThis study tested a drug called KLH-2109 in 89 premenopausal Japanese women with uterine fibroids who had heavy bleeding and pain. The goal was to see if the drug could reduce bleeding and pain better than a placebo. Results will show if this drug can help manage symptoms without…
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 08:47 UTC
-
New drug offers hope for dialysis Patients' relentless itching
Symptom relief CompletedThis study tested a drug called MR13A9 for people on dialysis who suffer from severe itching. 247 Japanese adults participated, and the drug was compared to a placebo to see if it safely reduces itch intensity. The goal was to find the right dose and confirm the drug's effects.
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 08:29 UTC
-
New drug offers hope for dialysis Patients' unbearable itching
Symptom relief CompletedThis study tested a drug called MR13A9 in 178 adults on hemodialysis who had severe itching not caused by other conditions. Participants rated their worst itch daily on a 0-10 scale. The study compared MR13A9 to a placebo to see if it better reduced itching over 4 weeks, then con…
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC